Pacira Pharmaceuticals, Inc. to Present at the Needham Healthcare Conference

PARSIPPANY, N.J., April 03, 2017 (GLOBE NEWSWIRE) -- Pacira Pharmaceuticals, Inc. (NASDAQ: PCRX) today announced that members of its management team are scheduled to present at the 16th Annual Needham Healthcare Conference at 3:00 PM ET on Tuesday, April 4, 2017, in New York.

A live audio webcast of the Pacira presentation can be accessed by visiting the “Investors & Media” section of the company’s website at investor.pacira.com. A replay of the webcast will be archived on the Pacira website for two weeks following the presentation date.

About Pacira                                                                           

Pacira Pharmaceuticals, Inc. (NASDAQ: PCRX) is a specialty pharmaceutical company focused on the clinical and commercial development of new products that meet the needs of acute care practitioners and their patients. The company’s flagship product, EXPAREL® (bupivacaine liposome injectable suspension), indicated for single-dose infiltration into the surgical site to produce postsurgical analgesia, was commercially launched in the United States in April 2012. EXPAREL and two other products have successfully utilized DepoFoam®, a unique and proprietary product delivery technology that encapsulates drugs without altering their molecular structure, and releases them over a desired period of time. Additional information about Pacira is available at www.pacira.com.

Company Contact:
Pacira Pharmaceuticals, Inc.
Susan Mesco
(973) 451-4030
[email protected]

You May Also Be Interested In

• PharmaCorp Rx Inc. Announces Board and Committee Changes
• Crypto News Today: AlphaPepe Nears Fourth CEX Reveal as the Ethereum Price Prediction Targets $12,000
• Top ABA Therapy Maps 4,206 ABA Provider Locations Nationwide